VICTORIA, British Columbia, June 23, 2020 (GLOBE NEWSWIRE) — A new poll indicates that 59% of Canadians approve the use of psilocybin-mushrooms for terminally-ill patients. Currently, psilocybin is illegal in Canada and classified as a Schedule III drug under the Controlled Drugs and Substances Act, making it inaccessible for medical purposes. However, mounting evidence from world class research organizations such as Johns Hopkins, NYU and UCLA indicate that psilocybin-assisted psychotherapy is both a safe and effective treatment option for end-of-life distress.
Share this post
